glp 1 agonists for type 2 diabetes GLP-1 receptor in the treatment of e Comparing Ozempic, Wegovy and Other
Description
doi: 10.1093/jnci/92.18.1472 206 BruntonSAWyshamCH
F.LingvayI.et al (2021)
In addition, GIP enhances the lipid buffering capacity of WAT in lipid metabolism and promotes suitable lipid allocation, thereby reducing ectopic fat deposition [134]
Retatrutide is setting new records at ~25% or more
doi: 10.2337/diab.45.6.832 144 HunterKHlscherC
To counter such impacts, some companies are exploring ways that GLP-1RA drugs could complement their existing solutions
